Carctol

From Wikipedia, the free encyclopedia
Jump to: navigation, search

Carctol is an ineffective cancer treatment made by mixing 8 Indian herbs.[1]

Carctol has been aggressively marketed as a being able to treat cancer and reduce the side-effects of chemotherapy. However, there is no medical evidence that it has any benefits whatsoever for people with cancer.[1]

Background and promotion[edit]

Carctol is a herbal dietary supplement marketed with claims it is based on traditional ayurvedic medicine.[1] Its ingredients include Hemidesmus indicus, Tribulus terrestris, Piper cubeba, Ammani vesicatoria, Lepidium sativum, Blepharis edulis, Smilax china and Rheum emodi.[1]

It was first promoted in 1968 by Nandlal Tiwari.[1] In 2009 Edzard Ernst wrote that it was still promoted in the United Kingdom; public relations companies hired by its sellers had garnered it wide coverage on the web and,[2] according to the British Medical Journal, in the media generally.[3]

Effectiveness and response[edit]

Cancer Research UK say of Carctol, "available scientific evidence does not support its use for the treatment of cancer in humans".[1] Edzard Ernst has written "the claim that Carctol is of any benefit to cancer patients is not supported by scientific evidence".[2]

Harriet A. Hall includes Carctol among the biologically-based remedies promoted by naturopaths. Hall laments that frauds and quacks persistently try to take advantage of the vulnerability of cancer patients.[4]

See also[edit]

References[edit]

  1. ^ a b c d e f "Carctol". Cancer Research UK. Retrieved 4 October 2013. 
  2. ^ a b Ernst, Edzard (2009). "Carctol: Profit before Patients?". Breast Care 4 (1): 31–33. doi:10.1159/000193025. PMC 2942009. PMID 20877681. 
  3. ^ Marks, N. (2004). "PR coup for herbal cancer drug". BMJ 329 (7469): 804. doi:10.1136/bmj.329.7469.804. 
  4. ^ Hall, Harriet A. (2012). "CAM for cancer: Preying on desperate people?". Progress in Palliative Care 20 (5): 295. doi:10.1179/1743291X12Y.0000000009.